Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Dec;36(6):730–742. doi: 10.1038/bjc.1977.256

Analysis of heteroantisera to cells from human malignant effusions by immunofluorescence and protein A binding.

J P Birchall, J J Owen, B S Owen
PMCID: PMC2025566  PMID: 339939

Abstract

Using cultured cells derived from human malignant effusions, hetero-antisera were raised in rabbits. The antisera were sequentially absorbed on various human non-tumour cells, reactivity being monitored by immunofluorescence and 125I-labelled staphylococcal protein A assays. The absorbed antisera possessed common reactivity to all tumour cells assayed. This reactivity was not histogenically determined, and our data suggest that it was not directed to oncofoetal antigens.

Full text

PDF
730

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avis F., Mosonov I., Haughton G. Antigenic cross-reactivity between benign and malignant neoplasms of the human breast. J Natl Cancer Inst. 1974 Apr;52(4):1041–1049. doi: 10.1093/jnci/52.4.1041. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Embleton M. J. Neoantigens on spontaneous and carcinogen-induced rat tumors defined by in vitro lymphocytotoxicity assays. Int J Cancer. 1974 Apr 15;13(4):433–443. doi: 10.1002/ijc.2910130402. [DOI] [PubMed] [Google Scholar]
  3. Brown G., Capellaro D., Greaves M. Leukemia-associated antigens in man. J Natl Cancer Inst. 1975 Dec;55(6):1281–1289. doi: 10.1093/jnci/55.6.1281. [DOI] [PubMed] [Google Scholar]
  4. Cailleau R., Mackay B., Young R. K., Reeves W. J., Jr Tissue culture studies on pleural effusions from breast carcinoma patients. Cancer Res. 1974 Apr;34(4):801–809. [PubMed] [Google Scholar]
  5. Dickinson J. P., Smith J. J., Dyson J. E. A cell-surface antigen common to human tumours: detection, localization and characterization. Biochem Soc Trans. 1976;4(1):125–127. doi: 10.1042/bst0040125. [DOI] [PubMed] [Google Scholar]
  6. Goodwin D. P., Hornung M. O., Leong S. P., Krementz E. T. Immune responses induced by human malignant melanoma in the rabbit. Surgery. 1972 Nov;72(5):737–743. [PubMed] [Google Scholar]
  7. Gorsky Y., Vanky F., Sulitzeanu D. Isolation from patients with breast cancer of antibodies specific for antigens associated with breast cancer and other malignant diseases. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2101–2105. doi: 10.1073/pnas.73.6.2101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grimm E. A., Silver H. K., Roth J. A., Chee D. O., Gupta R. K., Morton D. L. Detection of tumor-associated antigen in human melanoma cell line supernatants. Int J Cancer. 1976 May 15;17(5):559–564. doi: 10.1002/ijc.2910170503. [DOI] [PubMed] [Google Scholar]
  9. Hellström I., Hellström K. E. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum. Int J Cancer. 1975 Jan 15;15(1):1–16. doi: 10.1002/ijc.2910150102. [DOI] [PubMed] [Google Scholar]
  10. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  11. Irie R. F., Irie K., Morton D. L. A membrane antigen common to human cancer and fetal brain tissues. Cancer Res. 1976 Sep;36(9 Pt 2):3510–3517. [PubMed] [Google Scholar]
  12. Kronvall G., Williams R. C., Jr Differences in anti-protein A activity among IgG subgroups. J Immunol. 1969 Oct;103(4):828–833. [PubMed] [Google Scholar]
  13. MURPHY W. H., LANDAU B. J. Clonal variation and interaction of cells with viruses. Natl Cancer Inst Monogr. 1962 Apr;7:249–271. [PubMed] [Google Scholar]
  14. McCoy J. L., Jerome L. F., Dean J. H., Perlin E., Oldham R. K., Char D. H., Cohen M. H., Felix E. L., Herberman R. B. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J Natl Cancer Inst. 1975 Jul;55(1):19–23. doi: 10.1093/jnci/55.1.19. [DOI] [PubMed] [Google Scholar]
  15. Mohanakumar T., Metzgar R. S., Miller D. S. Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst. 1974 May;52(5):1435–1444. doi: 10.1093/jnci/52.5.1435. [DOI] [PubMed] [Google Scholar]
  16. Richman A. V. Immunofluorescence studies of benign and malignant human mammary tissue. J Natl Cancer Inst. 1976 Aug;57(2):263–267. doi: 10.1093/jnci/57.2.263. [DOI] [PubMed] [Google Scholar]
  17. SHULMAN N. R., MARDER V. J., HILLER M. C., COLLIER E. M. PLATELET AND LEUKOCYTE ISOANTIGENS AND THEIR ANTIBODIES: SEROLOGIC PHYSIOLOGIC AND CLINICAL STUDIES. Prog Hematol. 1964;4:222–304. [PubMed] [Google Scholar]
  18. Seibert E., Sorg C., Happle R., Macher E. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells. Int J Cancer. 1977 Feb 15;19(2):172–178. doi: 10.1002/ijc.2910190206. [DOI] [PubMed] [Google Scholar]
  19. Shiku H., Takahashi T., Oettgen H. F. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med. 1976 Oct 1;144(4):873–881. doi: 10.1084/jem.144.4.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Souhami R., Owen J. J., Seeger R. C. A method for growing, freeze-storing and isotopically labelling human tumour cells for in vitro assays of tumour immunity. J Immunol Methods. 1974 Jul;5(2):137–146. doi: 10.1016/0022-1759(74)90004-0. [DOI] [PubMed] [Google Scholar]
  21. Stuhlmiller G. M., Seigler H. F. Characterization of a chimpanzee anti-human melanoma antiserum. Cancer Res. 1975 Aug;35(8):2132–2137. [PubMed] [Google Scholar]
  22. Weiner R. S., Hubbard J. D., Mardiney M. R., Jr Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody. J Natl Cancer Inst. 1972 Oct;49(4):1063–1070. [PubMed] [Google Scholar]
  23. Whitehead R. H., Hughes L. E. Tissue culture studies of malignant effusions. Br J Cancer. 1975 Oct;32(4):512–518. doi: 10.1038/bjc.1975.254. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES